A Dose Escalation Study of Proton and Carbon Ion Irradiation for HER2 Positive and Triple Negative Breast Cancer

Clinical trial NCT05692661 · UNKNOWN

Trial details

NCT number: NCT05692661
Sponsor: Shanghai Proton and Heavy Ion Center
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Triple Negative Breast Cancer HER2-positive Breast Cancer

Start date: 2023-01-10
Primary completion: 2025-10-10
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.